December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
SENTRY study – investigating the safety and efficacy of the combination of selinexor plus ruxolitinib in myelofibrosis
Aug 12, 2024, 13:49

SENTRY study – investigating the safety and efficacy of the combination of selinexor plus ruxolitinib in myelofibrosis

Icahn School of Medicine at Mount Sinai shared on X:

The SENTRY study, led by Dr. John Mascarenhas, is investigating the safety and efficacy of the combination of selinexor (Xpovio) plus ruxolitinib (Jakafi) for the treatment of patients with JAK inhibitor treatment-naive myelofibrosis.”

Read further.
Source: Icahn School of Medicine at Mount Sinai/X